Results show daclizumab to be effective in reducing relapse rate and new lesions in relapsing-remitting MS
The Brazilian MS Association (ABEM) is contributing to a Sao Paulo based campaign to highlight the importance of mental health and mental health professionals
On 21st October, MS Ireland launched a report on the costs of multiple sclerosis to Irish society
There are two World Days coming up which will be of interest to the global MS community.
Which of these MS research areas would you like to hear more about?
We spoke to an Argentinian researcher studying the correlation between melatonin and MS
Chemical in the brain involved in signaling may play a role in progressive MS
The results of a seven-year follow-up study confirm the safety and efficacy of fingolimod
A German study shows that exclusive breastfeeding does not increase the risk of relapse after childbirth
Current and past fellows of MSIF and ECTRIMS come together in Barcelona to share experiences
Study suggests that melatonin could be a possible cause of seasonal changes in MS disease activity
We are seeking a Research Insight Analyst for a project this November